Comparator QIV: Clinical Trials

4 completed. 4 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	4	Completed 4

Follow Comparator QIV: new trials by email Literature Review of Comparator QIV trials Research Report on Comparator QIV

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Clinical Study to Evaluate the Immunogenicity and Safety of an Adjuvanted Quadrivalent Influenza Vaccine Compared With a Licensed Quadrivalent Vaccine in Adults 50 to 64 Years of Age aQIV, Comparator QIV - Influenza, Human	Phase 3	Completed	Seqirus	2044	2021-09-30	2023-09-28
Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects QIVc, Comparator QIV - Influenza, Human	Phase 3	Completed	Seqirus	2414	2019-09-06	2022-01-12
A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age. Seqirus Quadrivalent Inactivated Influenza Vaccine, Comparator Quadrivalent Inactivated Influenza Vaccine - Influenza, Human	Phase 3	Completed	Seqirus	2250	2016-09-27	2019-01-23
A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of Age Seqirus QIV, Comparator QIV - Influenza, Human	Phase 3	Completed	Seqirus	2278	2015-09-01	2018-05-23

Conditions studied

Influenza, Human (4)  ·  Virus Diseases (1)

Sponsors

Seqirus (4)

Countries

United States (4)  ·  Estonia (1)  ·  Germany (1)

Results publications

PMID 28390934, PMID 30057283, PMID 36214072